Is Novo Nordisk Stock a Buy Right Now?
Novo Nordisk stock has been pretty volatile lately, making it hard to judge whether now is a good opportunity to buy shares.
24/7 Wall St22h
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
A Scandinavian economic behemoth, Novo Nordisk is the highest valued company in Europe at over $500 billion, which ...
Daily7h
Novo Nordisk Enters China's Obesity Market with Wegovy Launch, Eyes 180 Million Patients
The move intensifies the competition with Eli Lilly, which secured approval for its weight loss drug in China in July but has ...
Benzinga.com2d
Novo Nordisk To Offer Wegovy In China At Fraction Of USA Cost
Novo Nordisk's Wegovy launch in China begins in Shanghai at $194 per four-injection pack, significantly cheaper than ...
BioSpace1h
Novo, Viking Heat Up MASH Space with Promising Data at AASLD24
Readouts from Novo Nordisk and Viking Therapeutics at AASLD 2024 strengthen the argument for GLP-1 therapies as an emerging ...
Novo Nordisk’s Blockbuster Wegovy Drug Sales Beat Expectations
The company narrowed its full-year guidance as its blockbuster weight-loss drug soars in popularity.
Copenhagen Post1d
Novo Nordisk launches wegovy in China
Danish pharmaceutical giant Novo Nordisk has introduced its weight loss drug, Wegovy, to the Chinese market. The launch, confirmed by the company via Reuters and first reported by Chinese business ...
STAT1d
Pharmalittle: We’re reading about a key Merck drug trial, cheap Wegovy in China, and more
Merck reported that a new formulation of Keytruda appears to deliver similar blood levels of the drug when given as a shot as ...